These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 16103722)
21. Exclusive breast-feeding and weaning: effect on serum cholesterol and lipoprotein concentrations in infants during the first year of life. Kallio MJ; Salmenperä L; Siimes MA; Perheentupa J; Miettinen TA Pediatrics; 1992 Apr; 89(4 Pt 1):663-6. PubMed ID: 1557248 [TBL] [Abstract][Full Text] [Related]
22. The effect of nutritional habits on maternal-neonatal lipid and lipoprotein serum levels in three different ethnic groups. Schulpis KH; Gavrili S; Vlachos G; Karikas GA; Michalakakou K; Demetriou E; Papassotiriou I Ann Nutr Metab; 2006; 50(3):290-6. PubMed ID: 16508258 [TBL] [Abstract][Full Text] [Related]
23. [Changes in HDL-cholesterol, subfractions HDL2 and HDL3 and apo-A, apo-A1 and apo-B lipoproteins in patients with chronic renal failure subjected to maintenance hemodialysis]. Scarazatti E; Garavaglia G Boll Soc Ital Biol Sper; 1985 Jan; 61(1):15-21. PubMed ID: 3977994 [TBL] [Abstract][Full Text] [Related]
24. Is there an association between intradialytic hypotension and serum magnesium changes? Pakfetrat M; Roozbeh Shahroodi J; Malekmakan L; Zare N; Hashemi Nasab M; Hossein Nikoo M Hemodial Int; 2010 Oct; 14(4):492-7. PubMed ID: 20955283 [TBL] [Abstract][Full Text] [Related]
25. Serum oxidized LDL is inversely associated with HDL2-cholesterol subclass in renal failure patients on hemodialysis. Samouilidou E; Karpouza A; Grapsa E; Tzanatou-Exarchou H Nephron Clin Pract; 2010; 115(4):c289-94. PubMed ID: 20424480 [TBL] [Abstract][Full Text] [Related]
26. Apoprotein A-I and high density lipoprotein subfractions in patients with chronic renal failure receiving hemodialysis. Joven J; Rubiés-Prat J; Espinel E; Chacón P; Olmos A; Masdeu S Nephron; 1985; 40(4):451-4. PubMed ID: 3927179 [TBL] [Abstract][Full Text] [Related]
27. Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients. Desmeules S; Arcand-Bossé JF; Bergeron J; Douville P; Agharazii M Am J Kidney Dis; 2005 Jun; 45(6):1067-72. PubMed ID: 15957136 [TBL] [Abstract][Full Text] [Related]
29. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease. Nishizawa Y; Shoji T; Kakiya R; Tsujimoto Y; Tabata T; Ishimura E; Nakatani T; Miki T; Inaba M Kidney Int Suppl; 2003 May; (84):S117-20. PubMed ID: 12694324 [TBL] [Abstract][Full Text] [Related]
30. [The significance of high-density lipoprotein subfractions and triglycerides in predicting coronary artery disease]. Jiang D; Wen D; Qi S Zhonghua Nei Ke Za Zhi; 1995 May; 34(5):298-301. PubMed ID: 8565710 [TBL] [Abstract][Full Text] [Related]
31. The Unexpected Effects of L-Carnitine Supplementation on Lipid Metabolism in Hemodialysis Patients. Katalinic L; Krtalic B; Jelakovic B; Basic-Jukic N Kidney Blood Press Res; 2018; 43(4):1113-1120. PubMed ID: 30016788 [TBL] [Abstract][Full Text] [Related]
32. Comparison of serum lipids, lipoproteins, and fibrinogen in patients with kidney transplantation and hemodialysis. Demirağ A; Moray G; Ozdemir N; Hizel N; Bilgin N; Haberal M Transplant Proc; 1998 Aug; 30(5):2052-3. PubMed ID: 9723389 [No Abstract] [Full Text] [Related]
33. L-carnitine supplementation in hemodialysis patients. Mitwalli AH; Al-Wakeel JS; Alam A; Tarif N; Abu-Aisha H; Rashed M; Al Nahed N Saudi J Kidney Dis Transpl; 2005; 16(1):17-22. PubMed ID: 18209454 [TBL] [Abstract][Full Text] [Related]
34. Hemodialysis reduces plasma apolipoprotein C-I concentration making VLDL a better substrate for lipoprotein lipase. Dautin G; Soltani Z; Ducloux D; Gautier T; Pais de Barros JP; Gambert P; Lagrost L; Masson D Kidney Int; 2007 Oct; 72(7):871-8. PubMed ID: 17667986 [TBL] [Abstract][Full Text] [Related]
35. Improvement in lipid profile by nocturnal hemodialysis in patients with end-stage renal disease. Bugeja AL; Chan CT ASAIO J; 2004; 50(4):328-31. PubMed ID: 15307542 [TBL] [Abstract][Full Text] [Related]
36. Effect of L-carnitine supplementation on lipid parameters in hemodialysis patients. Elisaf M; Bairaktari E; Katopodis K; Pappas M; Sferopoulos G; Tzallas C; Tsolas O; Siamopoulos KC Am J Nephrol; 1998; 18(5):416-21. PubMed ID: 9730566 [TBL] [Abstract][Full Text] [Related]
37. Serum L-carnitine levels and lipoprotein compositions in chronic viral hepatitis patients. Eskandari GH; Kandemir O ; Polat G; Tamer L; Ersöz G; Atik U Clin Biochem; 2001 Jul; 34(5):431-3. PubMed ID: 11522283 [TBL] [Abstract][Full Text] [Related]
38. HDL-cholesterol subfractions in healthy males: relation to serum triglyceride levels and age. Ferns GA; Robinson D; Stocks J; Bevan E; Williams P; Galton DJ Ann Clin Biochem; 1986 Sep; 23 ( Pt 5)():504-8. PubMed ID: 3767284 [TBL] [Abstract][Full Text] [Related]
39. Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue. Pistone G; Marino A; Leotta C; Dell'Arte S; Finocchiaro G; Malaguarnera M Drugs Aging; 2003; 20(10):761-7. PubMed ID: 12875611 [TBL] [Abstract][Full Text] [Related]
40. Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients. Piperi C; Kalofoutis C; Tzivras M; Troupis T; Skenderis A; Kalofoutis A Mol Cell Biochem; 2004 Oct; 265(1-2):57-61. PubMed ID: 15543934 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]